Our Contributors
Latest from BioTech Health X
- Virios Therapeutics Stock Plunges 70% on Fibromyalgia Clinical Trial Failure Results
- CEL-SCI Multikine Phase 3 Data Highlighted at ESMO 2022
- Mayo Clinic, Hibiscus BioVentures, and Innoforce Announce Mayflower Cell and Gene Therapy Accelerator
- SyneuRx CEO Dr. Emil Tsai Exclusive Interview with Insights & Projections
- Krystal Biotech Announces FDA IND Acceptance for KB407 Cystic Fibrosis Clinical Trial
- ImmunityBio Announces FDA Acceptance of BLA for N-803 Anktiva Bladder Cancer Drug
Studied UC Davis School of Medicine.
Enjoy Surfing, Sunning and Helping People.
Bylines and analysis in Biotech on major publications.
Current Biotech Analyst & Consultant.
Latest from Jak Thomson
- MacroGenics Announces Failure in SOPHIA Study of MARGENZA for Metastatic Breast Cancer Patients
- Exclusive: Cel-Sci CEO Geert Kersten Talks Multikine, FDA Approval, CVM Future
- Denali Therapeutics Announces Scientific Journal Publication of Preclinical Proof of Concept for Protein Transport Vehicle (PTV)
- Indapta Therapeutics Announces Data Demonstrating G-NK Cells Enhance Efficacy in Multiple Myeloma
- Presenters Announced for 2021 William Blair Biotech Conference
- BenchSci Expands Advisory Board with New Pharma R&D Leaders